6 Insiders Buy $AKTS (Jan 12, 2026 - Jan 12, 2026) | Average Insider

Aktis Oncology, Inc. ($AKTS)

Jan 12, 2026 - Jan 12, 2026

📈 Chart on TradingView 💰 Financials on Finviz

6 Participants

52W Low$14.72

Current$18.6026.9% above low, 73.1% below high

Purchase$18.0022.7% above low, 77.3% below high

52W High$29.16

Total Shares

5,371,203

Total Value

$96,681,654.00

Avg P&L

+3.3%

Timeframe

0 days

Total P&L

-2.1% ($1,987,345.11)

Participants

Name	Title	Security	Derivative	Filing Date	Transaction Date	Type	Shares	Price	Total Cost	Shares After	Direct/Indirect	Nature of Ownership	Actions
Kim Helen Susan	Director	Common Stock	—	Jan 12, 2026	Jan 12, 2026	P	812,455	$18.00	$14,624,190.00	5,671,825	Indirect	See Footnote	View Details
Vida Ventures II, LLC	10% Owner	Common Stock	—	Jan 12, 2026	Jan 12, 2026	P	22,545	$18.00	$405,810.00	157,387	Indirect	See Footnote	View Details
EcoR1 Capital, LLC	Director	Common Stock	—	Jan 12, 2026	Jan 12, 2026	P	2,077,779	$18.00	$37,400,022.00	4,348,658	Indirect	See Note	View Details
MPM BIOVENTURES 2018, L.P.	10% Owner	Common Stock	—	Jan 12, 2026	Jan 12, 2026	P	1,112,777	$18.00	$20,029,986.00	10,260,064	Indirect	See Footnote	View Details
GADICKE ANSBERT	10% Owner	Common Stock	—	Jan 12, 2026	Jan 12, 2026	P	1,112,777	$18.00	$20,029,986.00	10,260,064	Indirect	See Footnote	View Details
Foley Todd	Director	Common Stock	—	Jan 12, 2026	Jan 12, 2026	P	232,870	$18.00	$4,191,660.00	4,235,403	Indirect	See Footnote	View Details

Version: v26.3.33